Stay tuned, leave your email
Articles récents
- UZEDY® Continues Strong Momentum in 2025; Olanzapine LAI on Track for FDA Filing in H2 2025
- Medincell and iM4TB Join Forces to Fight Tuberculosis
- Increase in the Amount Allocated to the Liquidity Contract
- Phase 3 Survey Results Demonstrate Patient and Healthcare Professional Satisfaction with Olanzapine LAI
- Medincell Strengthens its Board of Directors
Commentaires récents
No comments to show.
